OBJECTIVE: To review the pathophysiology of atherosclerosis, the role of the renin—
angiotensin system in atherogenesis, and studies supporting the potential beneficial effects …

Angiotensin-converting enzyme (ACE) inhibitors are well established as first-line therapy for
patients with left ventricular dysfunction, diabetic patients with hypertension or renal disease …

The renin-angiotensin system and angiotensin-converting enzyme (ACE) are increasingly
being implicated in the pathogenesis of coronary artery disease and its sequelae and the …

Recent clinical data from the SOLVD (Studies on Left Ventricular Dysfunction) and SAVE
(Survival and Ventricular Enlargement) studies have shown a significant reduction in …

Purpose: To review the evidence on the effects of angiotensin converting enzyme (ACE)
inhibitors in coronary artery disease. Experimental studies: In studies of experimental …

Angiotensin-converting enzyme (ACE) inhibitors appear to possess unique cardioprotective
benefits, even when used in patients without high blood pressure or left ventricular …

Angiotensin-converting enzyme (ACE) inhibitors have played a highly beneficial role in the
therapy of hypertension and congestive heart failure. Detailed analysis of some of the heart …

Angiotensin-converting enzyme inhibitors have been extensively studied and established in
the treatment of hypertension, heart failure, and ventricular dysfunction. They have various …

Protection of the endothelium, the metabolically active inner lining of the vasculature,
appears to be a key factor in maintaining cardiovascular (CV) health. The endothelium …

Angiotensin II, a potent vasoconstrictor, is mainly present in the vascular endothelium.
Multiple studies have confirmed that angiotensin-converting enzyme (ACE) inhibitors, which …